Preferred Label : plant extracts;
MeSH definition : Concentrated pharmaceutical preparations of plants obtained by removing active constituents
with a suitable solvent, which is evaporated away, and adjusting the residue to a
prescribed standard.;
MeSH synonym : extracts, plant; Plant Extract; Extract, Plant;
Related MeSH term : Medicines, Herbal;
MeSH annotation : coordinate with specific plant and PLANT STRUCTURES term if pertinent; for use in
therapy coordinate IM or NIM with phytotherapy (IM) disease / drug ther (IM); extracts
of medicinal plants in Chinese medicine PLANT EXTRACTS, CHINESE see DRUGS, CHINESE
HERBAL;
Origin ID : D010936;
UMLS CUI : C0032081;
Allowable qualifiers
Currated CISMeF NLP mapping
Indexing information
- 4-hydroxy-7,7',8,8',11,11',12,12',15,15'-decahydro-beta,psi-carotene [MeSH Supplementary Concept]
- MAR 10 [MeSH Supplementary Concept]
- SGF gum [MeSH Supplementary Concept]
- WS 1442 [MeSH Supplementary Concept]
- achook [MeSH Supplementary Concept]
- allixin [MeSH Supplementary Concept]
- aralin [MeSH Supplementary Concept]
- bilobol [MeSH Supplementary Concept]
- butin [MeSH Supplementary Concept]
- curine [MeSH Supplementary Concept]
- emospid [MeSH Supplementary Concept]
- ferujol [MeSH Supplementary Concept]
- filicin [MeSH Supplementary Concept]
- fraxin [MeSH Supplementary Concept]
- hinesol [MeSH Supplementary Concept]
- iberin [MeSH Supplementary Concept]
- kutkin [MeSH Supplementary Concept]
- lucidin [MeSH Supplementary Concept]
- maesol [MeSH Supplementary Concept]
- nomilin [MeSH Supplementary Concept]
- osajin [MeSH Supplementary Concept]
- oxyline [MeSH Supplementary Concept]
- persin [MeSH Supplementary Concept]
- sarisan [MeSH Supplementary Concept]
- shogaol [MeSH Supplementary Concept]
- silibor [MeSH Supplementary Concept]
- tanacin [MeSH Supplementary Concept]
- taxine [MeSH Supplementary Concept]
- totarol [MeSH Supplementary Concept]
Record concept(s)
Related MeSH Supplementary Concept(s)
- 5-Loxin [MeSH Supplementary Concept]
- AS 195 [MeSH Supplementary Concept]
- AXOL [MeSH Supplementary Concept]
- CKD-497 [MeSH Supplementary Concept]
- COLD-fX [MeSH Supplementary Concept]
- Capilen [MeSH Supplementary Concept]
- ColiMil [MeSH Supplementary Concept]
- Cranpac [MeSH Supplementary Concept]
- D 400 [MeSH Supplementary Concept]
- D-Worm [MeSH Supplementary Concept]
- DA 9601 [MeSH Supplementary Concept]
- DA-5204 [MeSH Supplementary Concept]
- DA-9201 [MeSH Supplementary Concept]
- DA-9401 [MeSH Supplementary Concept]
- DA-9805 [MeSH Supplementary Concept]
- DAS-77 [MeSH Supplementary Concept]
- DT56a [MeSH Supplementary Concept]
- E-721B [MeSH Supplementary Concept]
- EH-1501 [MeSH Supplementary Concept]
- EH0202 [MeSH Supplementary Concept]
- ERr 731 [MeSH Supplementary Concept]
- ESP 102 [MeSH Supplementary Concept]
- Entoban [MeSH Supplementary Concept]
- F 14001 [MeSH Supplementary Concept]
- FIBS [MeSH Supplementary Concept]
- FM 100 [MeSH Supplementary Concept]
- Furosap [MeSH Supplementary Concept]
- GC-7101 [MeSH Supplementary Concept]
- GutGard [MeSH Supplementary Concept]
- HP 200 [MeSH Supplementary Concept]
- HT008-1 [MeSH Supplementary Concept]
- HT1001 [MeSH Supplementary Concept]
- HX106N [MeSH Supplementary Concept]
- HemoHIM [MeSH Supplementary Concept]
- IDS 23 [MeSH Supplementary Concept]
- IDS 30 [MeSH Supplementary Concept]
- IGOB131 [MeSH Supplementary Concept]
- IM 133 [MeSH Supplementary Concept]
- Immu-25 [MeSH Supplementary Concept]
- JKTM-12 [MeSH Supplementary Concept]
- JSOG-6 [MeSH Supplementary Concept]
- KIOM 79 [MeSH Supplementary Concept]
- KOB03 [MeSH Supplementary Concept]
- Kepar [MeSH Supplementary Concept]
- LASAP-C [MeSH Supplementary Concept]
- LI 1370 [MeSH Supplementary Concept]
- LI 150 [MeSH Supplementary Concept]
- Levorag [MeSH Supplementary Concept]
- MD1 [MeSH Supplementary Concept]
- NP 06-1 [MeSH Supplementary Concept]
- ON101 [MeSH Supplementary Concept]
- ONC-107 [MeSH Supplementary Concept]
- Oakin [MeSH Supplementary Concept]
- Ocoxin [MeSH Supplementary Concept]
- PCM 4 [MeSH Supplementary Concept]
- PCT-233 [MeSH Supplementary Concept]
- PF-2405 [MeSH Supplementary Concept]
- PM 40 [MeSH Supplementary Concept]
- PN M001 [MeSH Supplementary Concept]
- RC-18 [MeSH Supplementary Concept]
- REGOPAR [MeSH Supplementary Concept]
- RICURA [MeSH Supplementary Concept]
- RN 180 [MeSH Supplementary Concept]
- RNI 249 [MeSH Supplementary Concept]
- Robuvit [MeSH Supplementary Concept]
- Ropren [MeSH Supplementary Concept]
- SAABMAL [MeSH Supplementary Concept]
- SPV 30 [MeSH Supplementary Concept]
- SR-T100 [MeSH Supplementary Concept]
- Semelil [MeSH Supplementary Concept]
- Serelys [MeSH Supplementary Concept]
- Slim339 [MeSH Supplementary Concept]
- TB 68 [MeSH Supplementary Concept]
- TJN 800 [MeSH Supplementary Concept]
- TJS 010 [MeSH Supplementary Concept]
- Tadenan [MeSH Supplementary Concept]
- Tutukon [MeSH Supplementary Concept]
- U'finer [MeSH Supplementary Concept]
- UDA-245 [MeSH Supplementary Concept]
- UL 409 [MeSH Supplementary Concept]
- UP1304 [MeSH Supplementary Concept]
- UP360 [MeSH Supplementary Concept]
- UP446 [MeSH Supplementary Concept]
- URG-71 [MeSH Supplementary Concept]
- Utipro [MeSH Supplementary Concept]
- WIB801C [MeSH Supplementary Concept]
- WIN 34B [MeSH Supplementary Concept]
- WS 1490 [MeSH Supplementary Concept]
- WS 5570 [MeSH Supplementary Concept]
- WS 5572 [MeSH Supplementary Concept]
- YY162 [MeSH Supplementary Concept]
- ZE 117 [MeSH Supplementary Concept]
- abana [MeSH Supplementary Concept]
- abisib [MeSH Supplementary Concept]
- acess-A [MeSH Supplementary Concept]
- aflapin [MeSH Supplementary Concept]
- agnolyt [MeSH Supplementary Concept]
- alcid V [MeSH Supplementary Concept]
- amole [MeSH Supplementary Concept]
- annatto [MeSH Supplementary Concept]
- aponin [MeSH Supplementary Concept]
- arctane [MeSH Supplementary Concept]
- arpadol [MeSH Supplementary Concept]
- asavam [MeSH Supplementary Concept]
- assalix [MeSH Supplementary Concept]
- aswal [MeSH Supplementary Concept]
- atrisin [MeSH Supplementary Concept]
- avemar [MeSH Supplementary Concept]
- avlimil [MeSH Supplementary Concept]
- bazoton [MeSH Supplementary Concept]
- boicil [MeSH Supplementary Concept]
- buddlin [MeSH Supplementary Concept]
- bushi [MeSH Supplementary Concept]
- catuama [MeSH Supplementary Concept]
- ceridal [MeSH Supplementary Concept]
- cyclo 3 [MeSH Supplementary Concept]
- cystone [MeSH Supplementary Concept]
- dermud [MeSH Supplementary Concept]
- desoris [MeSH Supplementary Concept]
- essiac [MeSH Supplementary Concept]
- eundan [MeSH Supplementary Concept]
- flamin [MeSH Supplementary Concept]
- folin [MeSH Supplementary Concept]
- gasex [MeSH Supplementary Concept]
- gencydo [MeSH Supplementary Concept]
- gentos [MeSH Supplementary Concept]
- gingium [MeSH Supplementary Concept]
- ginkor [MeSH Supplementary Concept]
- gitadyl [MeSH Supplementary Concept]
- gosyuyu [MeSH Supplementary Concept]
- grazax [MeSH Supplementary Concept]
- guduchi [MeSH Supplementary Concept]
- guhong [MeSH Supplementary Concept]
- gur [MeSH Supplementary Concept]
- heantos [MeSH Supplementary Concept]
- helixor [MeSH Supplementary Concept]
- hova [MeSH Supplementary Concept]
- imupret [MeSH Supplementary Concept]
- jigrine [MeSH Supplementary Concept]
- kalms [MeSH Supplementary Concept]
- kamala [MeSH Supplementary Concept]
- kosso [MeSH Supplementary Concept]
- kyolic [MeSH Supplementary Concept]
- lipotab [MeSH Supplementary Concept]
- litiax [MeSH Supplementary Concept]
- liv 100 [MeSH Supplementary Concept]
- liv 52 [MeSH Supplementary Concept]
- livwin [MeSH Supplementary Concept]
- livzon [MeSH Supplementary Concept]
- lo 701 [MeSH Supplementary Concept]
- lochein [MeSH Supplementary Concept]
- maksar [MeSH Supplementary Concept]
- masheri [MeSH Supplementary Concept]
- mentat [MeSH Supplementary Concept]
- miroton [MeSH Supplementary Concept]
- moraz [MeSH Supplementary Concept]
- mustong [MeSH Supplementary Concept]
- myron [MeSH Supplementary Concept]
- naksol [MeSH Supplementary Concept]
- nas [MeSH Supplementary Concept]
- nifadin [MeSH Supplementary Concept]
- nosulin [MeSH Supplementary Concept]
- ormobyl [MeSH Supplementary Concept]
- oxxynea [MeSH Supplementary Concept]
- palgin [MeSH Supplementary Concept]
- pecarin [MeSH Supplementary Concept]
- pitamin [MeSH Supplementary Concept]
- praneem [MeSH Supplementary Concept]
- prelox [MeSH Supplementary Concept]
- prospan [MeSH Supplementary Concept]
- renexin [MeSH Supplementary Concept]
- rhinax [MeSH Supplementary Concept]
- rosanol [MeSH Supplementary Concept]
- rucedal [MeSH Supplementary Concept]
- salinum [MeSH Supplementary Concept]
- salvin [MeSH Supplementary Concept]
- samital [MeSH Supplementary Concept]
- sanox [MeSH Supplementary Concept]
- saparal [MeSH Supplementary Concept]
- sarapin [MeSH Supplementary Concept]
- sasim [MeSH Supplementary Concept]
- scagel [MeSH Supplementary Concept]
- sedatol [MeSH Supplementary Concept]
- setarud [MeSH Supplementary Concept]
- soamsan [MeSH Supplementary Concept]
- sobatum [MeSH Supplementary Concept]
- taheebo [MeSH Supplementary Concept]
- teecura [MeSH Supplementary Concept]
- ulsan D [MeSH Supplementary Concept]
- urgenin [MeSH Supplementary Concept]
- uriston [MeSH Supplementary Concept]
- urodyn [MeSH Supplementary Concept]
- viusid [MeSH Supplementary Concept]
- vocara [MeSH Supplementary Concept]
- yahom [MeSH Supplementary Concept]
- yamoa [MeSH Supplementary Concept]
- ze 339 [MeSH Supplementary Concept]
- ze 450 [MeSH Supplementary Concept]
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Concentrated pharmaceutical preparations of plants obtained by removing active constituents
with a suitable solvent, which is evaporated away, and adjusting the residue to a
prescribed standard.
https://www.anses.fr/fr/content/avis-2019-sa-0155
2024
false
false
false
France
French
scientific and technical information
plant extracts
plant preparations
dietary supplements
guidelines as topic
---
https://www.has-sante.fr/jcms/p_3394096/fr/filsuvez-extrait-sec-raffine-d-ecorce-de-bouleau-epidermolyse-bulleuse-dystrophique
2022
false
false
false
France
plant extracts
treatment outcome
insurance, health, reimbursement
epidermolysis bullosa dystrophica
infant
child
adolescent
adult
aged
gels
administration, cutaneous
Oleogel-S10
Betulae cortex
evaluation of the transparency committee
plant bark
betula
---
https://www.ema.europa.eu/en/medicines/human/EPAR/filsuvez
2022
false
false
false
Netherlands
French
English
Oleogel-S10
Oleogel-S10
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Betulae cortex
orphan drug production
epidermolysis bullosa, junctional
adult
child
adolescent
betula
plant extracts
epidermolysis bullosa dystrophica
plant bark
drug approval
europe
administration, cutaneous
gels
pregnancy
breast feeding
drug evaluation, preclinical
aged
---
https://www.has-sante.fr/jcms/p_3380157/fr/filsuvez-extrait-sec-raffine-d-ecorce-de-bouleau-traitement-plaies
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
epidermolysis bullosa dystrophica
epidermolysis bullosa, junctional
plant extracts
infant
child
administration, cutaneous
evaluation of the transparency committee
betula
plant bark
---
https://ansm.sante.fr/actualites/lautorisation-de-mise-sur-le-marche-du-medicament-prodinan-palmier-de-floride-est-annulee-a-compter-du-22-avril-2021
2021
false
false
false
France
French
drug information
drug recalls
saw palmetto extract
plant extracts
---
https://www.has-sante.fr/jcms/p_3180084/fr/palmier-de-floride-pharmatoka
2020
false
true
false
France
plant extracts
Sabalis serrulatae fructus
administration, oral
insurance, health, reimbursement
treatment outcome
adult
urination disorders
prostatic hypertrophy, benign
evaluation of the transparency committee
serenoa
prostatic hyperplasia
---
https://www.acadpharm.org/dos_public/CANNABIS__ANP_2019.06.12_VF.pdf
2019
false
false
false
France
medical marijuana
cannabis
plant extracts
popular works
---
https://www.cochrane.org/fr/CD013106/radix-sophorae-flavescentis-par-rapport-dautres-medicaments-ou-plantes-pour-lhepatite-b-chronique
2019
false
true
false
false
France
United Kingdom
sophora
plant extracts
hepatitis B, chronic
treatment outcome
drugs, chinese herbal
randomized controlled trials as topic
plants, medicinal
plant extracts
review of literature
french abstract
---
https://www.cochrane.org/fr/CD013089/radix-sophorae-flavescentis-pour-le-traitement-de-lhepatite-b-chronique
2019
false
false
false
France
United Kingdom
plant extracts
treatment outcome
Sophora flavescens Root
sophora
review of literature
french abstract
hepatitis B, chronic
---
https://www.has-sante.fr/portail/jcms/c_2801977/fr/palmier-de-floride-biogaran
2017
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
Sabalis serrulatae fructus
treatment outcome
insurance, health, reimbursement
plant extracts
prostatic hypertrophy, benign
urination disorders
adult
serenoa
prostatic hyperplasia
---
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2017/65100a-fra.php
2017
false
false
false
Canada
French
vigilance note
Green Tea
plant extracts
Green Tea Extract
Chemical and Drug Induced Liver Injury
adult
Green Tea Extract-based Antioxidant Supplement
administration, oral
popular works
tea
plant extracts
---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2016.02501/
2016
false
false
false
Switzerland
French
journal article
medical marijuana
multiple sclerosis
spasm
muscle cramp
medical marijuana
treatment outcome
plant extracts
plant extracts
---
http://www.has-sante.fr/portail/jcms/c_2658594/fr/tussipax
http://www.has-sante.fr/portail/jcms/c_1072237/tussipax
http://www.has-sante.fr/portail/jcms/c_456635/fr/tussipax
2016
false
France
French
cough
dry cough
administration, oral
drug combinations
codeine
plant extracts
ethylmorphine
antitussive agents
combinations
insurance, health, reimbursement
verbascum
papaver
althaea
malva
tussilago
viola
asteraceae
pharmaceutical solutions
tablets
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/Episalvan
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
betula
plant extracts
plant bark
plant extracts
adult
administration, cutaneous
gels
Wound of skin (disorder)
burns
skin transplantation
wound healing
keratinocytes
wounds and injuries
product surveillance, postmarketing
drug monitoring
betulin
betulin
drug evaluation, preclinical
Dry extract (qualifier value)
Betulae cortex
triterpenes
triterpenes
---
http://www.has-sante.fr/portail/jcms/c_2565112/fr/prodinan
2015
false
true
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
saw palmetto extract
treatment outcome
serenoa
prostatic hyperplasia
Sabalis serrulatae fructus
urination disorders
plant extracts
---
http://www.has-sante.fr/portail/jcms/c_2023876/fr/prunier-d-afrique-mylan
http://www.has-sante.fr/portail/jcms/c_808791/prunier-d-afrique-mylan
2015
false
true
false
France
French
evaluation of the transparency committee
administration, oral
Tadenan
Prunus africanae cortex
insurance, health, reimbursement
treatment outcome
prostatic hypertrophy, benign
prostatic hyperplasia
plant extracts
fatty alcohols
---
http://www.has-sante.fr/portail/jcms/c_2580834/fr/arnica-boiron
http://www.has-sante.fr/portail/jcms/c_996909/arnica-boiron
2015
false
France
French
homeopathy
plant extracts
other therapeutic products
ointments
administration, cutaneous
insurance, health, reimbursement
arnica
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2024785/fr/permixon
http://www.has-sante.fr/portail/display.jsp?id=c_866789
2015
false
France
French
prostatic hypertrophy, benign
urination disorders
plant extracts
saw palmetto extract
administration, oral
serenoa
prostatic hyperplasia
Sabalis serrulatae fructus
insurance, health, reimbursement
plant extracts
evaluation of the transparency committee
---
http://www.cochrane.org/fr/CD000530/echinacea-pour-la-prevention-et-le-traitement-du-rhume-banal
2014
false
false
false
France
United Kingdom
French
french abstract
common cold
echinacea
treatment outcome
common cold
plant extracts
review of literature
---
http://www.has-sante.fr/portail/jcms/c_1765933/fr/veregen
2014
false
true
false
France
French
evaluation of the transparency committee
guidelines for drug use
administration, cutaneous
ointments
treatment outcome
condylomata acuminata
catechin
camellia sinensis
plant extracts
plant leaves
sinecatechins
insurance, health, reimbursement
---
https://minerva-ebp.be/FR/Article/19
2014
true
false
Belgium
French
critical appraisal or critical reading
serenoa repens
serenoa
treatment outcome
phytotherapy
plant extracts
prostatic hyperplasia
Sabalis serrulatae fructus
serenoa
---
http://www.cochrane.org/fr/CD007371
2013
United Kingdom
France
French
meta-analysis
intermittent claudication
treatment outcome
padma 28
plant extracts
french abstract
---
http://www.agritox.anses.fr/
true
France
French
plants, medicinal
plant extracts
phytotherapy
plants, toxic
database
---
https://minerva-ebp.be/fr/article/190
2012
false
false
minerva-ebm.be
Belgium
Dutch
French
secondary prevention
Fruit and Vegetable Juices
vaccinium macrocarpon
plant extracts
administration, oral
urinary tract infections
treatment outcome
critical appraisal or critical reading
---
http://www.cochrane.org/fr/CD001423
2012
United Kingdom
France
French
meta-analysis
serenoa
treatment outcome
phytotherapy
plant extracts
prostatic hyperplasia
Sabalis serrulatae fructus
french abstract
---
http://www.has-sante.fr/portail/jcms/c_1121566/vitalogink
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/vitalogink_02-11-2011_ct-11366.pdf
2011
France
French
evaluation of the transparency committee
risk assessment
cardiovascular agents
insurance, health, reimbursement
treatment outcome
administration, oral
ginkgo biloba
plant extracts
cognition disorders
intermittent claudication
vision disorders
hearing loss
tinnitus
dizziness
vertigo
raynaud disease
Ginkgo biloba extract
---
https://minerva-ebp.be/fr/article/233
2011
false
true
false
false
minerva-ebm.be
Belgium
child
child, preschool
respiratory tract infections
camphor, cedar leaf oil, eucalyptus oil, menthol, myristica oil, terebinth oil, thymol
drug combination
critical appraisal or critical reading
ointments
cough
plant extracts
terpenes
drug combinations
---
http://www.has-sante.fr/portail/jcms/c_1198548/ginkgo-biogaran
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-02/gingko_biogaran_02112012_avis_ct11521.pdf
2011
France
French
ginkgo biloba
plant extracts
phytotherapy
plant leaves
administration, oral
insurance, health, reimbursement
treatment outcome
Cognitive Dysfunction
intermittent claudication
vision disorders
hearing loss
tinnitus
vertigo
vascular diseases
raynaud disease
evaluation of the transparency committee
---
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=292&lang=eng
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=292&lang=fra
2011
Canada
English
French
secondary prevention
monograph pharmacy
vaccinium macrocarpon
plant extracts
fruit
phytotherapy
administration, oral
urinary tract infections
adult
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63262126
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=63262126&typedoc=N&ref=N0177706.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=63262126&typedoc=R&ref=R0177706.htm
2010
France
French
adult
pregnancy
plant extracts
plant extracts
plant roots
phytotherapy
Sleep Wake Disorders
capsules
valerian
package leaflet
summary of product characteristics
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/grazax_-_ct-8228.pdf
http://www.has-sante.fr/portail/jcms/c_1004916/grazax-extrait-allergenique-standardise-de-fleole-des-pres-lyophilisat-oral
2010
France
French
administration, sublingual
antigens, plant
desensitization, immunologic
grass pollen
insurance, health, reimbursement
child
conjunctivitis, allergic
rhinitis, allergic, seasonal
treatment outcome
evaluation of the transparency committee
guidelines for drug use
grazax
phleum
pollen
plant extracts
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60425707
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=60425707&typedoc=R&ref=R0170320.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=60425707&typedoc=N&ref=N0170320.htm
2010
false
France
French
tablets
dactylis
poaceae
lolium
desensitization, immunologic
pollen
antigens, plant
antigens, plant
administration, sublingual
adult
adolescent
child
plant extracts
grass pollen
poa
phleum
rhinitis, allergic, seasonal
conjunctivitis, allergic
summary of product characteristics
package leaflet
---
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=279&lang=fra
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=279&lang=eng
2010
Canada
English
French
serenoa
plant extracts
plant extracts
administration, oral
adult
phytotherapy
prostatic hyperplasia
phytosterols
fatty acids
monograph pharmacy
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63208057
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=63208057&typedoc=R&ref=R0162721.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=63208057&typedoc=N&ref=N0162721.htm
2009
France
French
grindelia
gelsemium
suppositories
acetaminophen
paracetamol, combinations excl. psycholeptics
administration, rectal
drug combinations
acetaminophen
analgesics, non-narcotic
analgesics, non-narcotic
plant extracts
plant extracts
drug interactions
pain
fever
child
cough
cough and cold preparations
antipyretics
antipyretics
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=68419955&typedoc=R&ref=R0164452.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=68419955&typedoc=N&ref=N0164452.htm
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68419955
2009
France
French
tablets
administration, oral
drug combinations
acetylsalicylic acid, combinations excl. psycholeptics
aspirin
aspirin
plant extracts
atropa belladonna
iris plant
caffeine
gelsemium
strychnos nux-vomica
loganiaceae
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
pain
fever
adult
adolescent
drug interactions
pregnancy
antipyretics
antipyretics
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_809786/atopiclair
http://www.has-sante.fr/portail/jcms/c_809789/atopiclair-cep-1948
2009
France
French
dermatitis, atopic
glycyrrhetinic acid
dermatologic agents
plant extracts
health technology assessment
drug evaluation
treatment outcome
---
https://cadth.ca/sites/default/files/cdr/complete/cdr_complete_Sativex-Resubmission_February-20-2008_Fr.pdf
2008
Canada
French
cannabinoids
psychotropic drugs
pain
plant extracts
analgesics
drug combinations
dronabinol
cannabidiol
plant extracts
drug evaluation
---
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=greentea_thevert&lang=fra
2008
Canada
French
English
camellia sinensis
plant extracts
plant leaves
phytotherapy
monograph pharmacy
---
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=100&lang=eng
2008
Canada
French
English
ginkgo biloba
plant extracts
plant leaves
phytotherapy
Ginkgo folium
monograph pharmacy
---
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=arnica&lang=fra
2008
Canada
French
English
arnica
plant extracts
flowers
administration, topical
phytotherapy
plant preparations
monograph pharmacy
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Sativex_September-26-2007_f.pdf
2007
Canada
French
cannabinoids
cannabidiol
neuralgia
plant extracts
multiple sclerosis
dronabinol
drug combinations
analgesics
plant extracts
drug evaluation
---
http://www.has-sante.fr/portail/display.jsp?id=c_487033
2007
France
French
drug combinations
erysimum
plant extracts
antitussive agents
pharmaceutical solutions
codeine
opium alkaloids and derivatives
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400861
2006
France
French
drug combinations
erysimum
plant extracts
antitussive agents
capsules
codeine
opium alkaloids and derivatives
evaluation of the transparency committee
---
https://minerva-ebp.be/fr/article/678
2006
false
false
minerva-ebm.be
Belgium
French
cimicifuga
plant extracts
treatment outcome
phytotherapy
climacteric
critical appraisal or critical reading
---
https://minerva-ebp.be/fr/article/717
2006
false
false
minerva-ebm.be
Belgium
French
hypericum
depressive disorder
paroxetine
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
adult
treatment outcome
phytotherapy
plant extracts
Hyperici herba
critical appraisal or critical reading
comparative study
---
http://www.has-sante.fr/portail/display.jsp?id=c_460041
2006
France
French
ginkor
troxerutin, combinations
drug combinations
plant extracts
troxerutin
heptaminol
ginkgo biloba
administration, oral
venous insufficiency
hemorrhoids
insurance, health, reimbursement
capsules
powders
hydroxyethylrutoside
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032752.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_448901
2006
France
French
plant extracts
ginkgo biloba
administration, oral
Ginkgo folium
Ginkgo biloba extract
ginkgolides
cognition disorders
plant extracts
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_451750
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032823.pdf
2006
France
French
dizziness
Ginkgo biloba extract
pharmaceutical solutions
administration, oral
plant extracts
ginkgo biloba
cognition disorders
intermittent claudication
vision disorders
raynaud disease
hearing loss
vascular diseases
treatment outcome
tablets
plant extracts
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031979.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400402
2005
France
French
evaluation of the transparency committee
tablets
administration, oral
drug combinations
cynara scolymus
plant extracts
phytotherapy
pyrola
Salicaceae
treatment outcome
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032018.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400441
2005
France
French
administration, oral
drug combinations
Vaccinium myrtillus extract
beta carotene
anthocyanins
plant extracts
treatment outcome
vision disorders
venous insufficiency
tablets
anthocyanins
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400470
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032047.pdf
2005
France
French
tablets
administration, oral
drug combinations
phytotherapy
Valerianae radix
plant extracts
crataegus extract
crataegus
passiflora
valerian
ballota
treatment outcome
anxiety disorders
Sleep Wake Disorders
child
adult
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031994.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400417
2005
France
French
tablets
administration, oral
crataegus
plant extracts
crataegus extract
phytotherapy
treatment outcome
anxiety disorders
Sleep Wake Disorders
neurocirculatory asthenia
adult
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400535
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032112.pdf
2005
France
French
administration, oral
pharmaceutical solutions
drug combinations
crataegus
plant extracts
phytotherapy
crataegus extract
passiflora
treatment outcome
neurocirculatory asthenia
Sleep Wake Disorders
anxiety disorders
adult
child
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400555
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032132.pdf
2005
France
French
valerian
Valerianae radix
treatment outcome
anxiety disorders
Sleep Wake Disorders
phytotherapy
suppositories
child
tablets
adult
administration, oral
administration, rectal
plant extracts
drug combinations
crataegus
crataegus extract
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400564
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032141.pdf
2005
France
French
tablets
administration, oral
drug combinations
crataegus
plant extracts
crataegus extract
eschscholzia
magnesium oxide
treatment outcome
neurocirculatory asthenia
anxiety disorders
Sleep Wake Disorders
adult
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032168.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400591
2005
France
French
administration, oral
drug combinations
plant extracts
tablets
crataegus
crataegus extract
melissa
calcium lactate
calcium compounds
lactates
magnesium compounds
treatment outcome
Sleep Wake Disorders
thiosulfates
neurocirculatory asthenia
lactates
calcium compounds
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400565
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032142.pdf
2005
France
French
pharmaceutical solutions
administration, oral
plant extracts
drug combinations
phytotherapy
crataegus
passiflora
adult
child
neurocirculatory asthenia
Sleep Wake Disorders
treatment outcome
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400550
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032127.pdf
2005
France
French
drug combinations
plant extracts
combretum
rosmarinus
treatment outcome
flowering tops
plant leaves
cholagogues and choleretics
phytotherapy
administration, oral
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031967.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400390
2005
France
French
crataegus
valerian
Avena
melissa
leonurus
administration, oral
drug combinations
plant extracts
passiflora
neurocirculatory asthenia
Sleep Wake Disorders
treatment outcome
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031956.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400379
2005
France
French
administration, oral
drug combinations
Lotus
melilotus
treatment outcome
phytotherapy
Sleep Wake Disorders
plant extracts
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032115.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400538
2005
France
French
administration, oral
drug combinations
plant extracts
asteraceae
phyllanthus
diuretics
treatment outcome
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400525
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032102.pdf
2005
France
French
sodium benzoate
plant extracts
polygala
grindelia
treatment outcome
combinations
expectorants
infant
administration, oral
drug combinations
pharmaceutical solutions
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032108.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400531
2005
France
French
administration, oral
drug combinations
esculin
aesculus
plant extracts
vitis
treatment outcome
venous insufficiency
hemorrhoids
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400494
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032071.pdf
2005
France
French
administration, oral
drug combinations
plant extracts
pulsatilla
esculin
capsella
aesculus
hamamelis
venous insufficiency
hemorrhoids
chronic disease
treatment outcome
evaluation of the transparency committee
---
https://minerva-ebp.be/fr/article/740
2005
false
false
minerva-ebm.be
Belgium
French
headache
antimigraine preparations
migraine disorders
treatment outcome
petasites
plant extracts
phytotherapy
migraine disorders
critical appraisal or critical reading
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032063.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400486
2004
France
French
administration, oral
pharmaceutical solutions
cynara scolymus
plant extracts
phytotherapy
treatment outcome
cholagogues and choleretics
diuretics
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031997.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400420
2004
France
French
tablets
pharmaceutical solutions
administration, oral
cynara scolymus
plant extracts
treatment outcome
phytotherapy
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032049.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400472
2004
France
French
evaluation of the transparency committee
administration, oral
phytotherapy
plant extracts
seeds
trigonella
treatment outcome
weight gain
appetite stimulants
---
http://www.has-sante.fr/portail/display.jsp?id=c_400394
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031971.pdf
2004
France
French
phytotherapy
administration, oral
drug combinations
plant extracts
betula
olea
diuretics
treatment outcome
evaluation of the transparency committee
---